299 related articles for article (PubMed ID: 22143497)
1. Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity.
Nogueira LM; Dunlap SM; Ford NA; Hursting SD
Endocr Relat Cancer; 2012 Feb; 19(1):57-68. PubMed ID: 22143497
[TBL] [Abstract][Full Text] [Related]
2. The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
De Angel RE; Conti CJ; Wheatley KE; Brenner AJ; Otto G; Degraffenried LA; Hursting SD
Mol Carcinog; 2013 Jun; 52(6):446-58. PubMed ID: 22290600
[TBL] [Abstract][Full Text] [Related]
3. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors.
Dogan S; Johannsen AC; Grande JP; Cleary MP
Nutr Cancer; 2011; 63(3):389-401. PubMed ID: 21462085
[TBL] [Abstract][Full Text] [Related]
4. Weight-cycling decreases incidence and increases latency of mammary tumors to a greater extent than does chronic caloric restriction in mouse mammary tumor virus-transforming growth factor-alpha female mice.
Cleary MP; Jacobson MK; Phillips FC; Getzin SC; Grande JP; Maihle NJ
Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):836-43. PubMed ID: 12223427
[TBL] [Abstract][Full Text] [Related]
5. Rapamycin partially mimics the anticancer effects of calorie restriction in a murine model of pancreatic cancer.
Lashinger LM; Malone LM; Brown GW; Daniels EA; Goldberg JA; Otto G; Fischer SM; Hursting SD
Cancer Prev Res (Phila); 2011 Jul; 4(7):1041-51. PubMed ID: 21593197
[TBL] [Abstract][Full Text] [Related]
6. Obesity accelerates mouse mammary tumor growth in the absence of ovarian hormones.
Nunez NP; Perkins SN; Smith NC; Berrigan D; Berendes DM; Varticovski L; Barrett JC; Hursting SD
Nutr Cancer; 2008; 60(4):534-41. PubMed ID: 18584488
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependent effects of calorie restriction on gene expression, metabolism, and tumor progression are partially mediated by insulin-like growth factor-1.
Nogueira LM; Lavigne JA; Chandramouli GV; Lui H; Barrett JC; Hursting SD
Cancer Med; 2012 Oct; 1(2):275-88. PubMed ID: 23342276
[TBL] [Abstract][Full Text] [Related]
8. Dietary restriction permits normal parturition and lactation but suppresses mouse mammary tumor virus proviral transcription even after mammary involution.
Engelman RW; Fukaura Y; Hamada N; Good RA; Day NK
Cancer Res; 1991 Oct; 51(19):5123-8. PubMed ID: 1655246
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer.
De Angel RE; Smith SM; Glickman RD; Perkins SN; Hursting SD
Nutr Cancer; 2010; 62(8):1074-86. PubMed ID: 21058195
[TBL] [Abstract][Full Text] [Related]
10. Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTV-TGF-alpha mice.
Rogozina OP; Bonorden MJ; Grande JP; Cleary MP
Cancer Prev Res (Phila); 2009 Aug; 2(8):712-9. PubMed ID: 19654106
[TBL] [Abstract][Full Text] [Related]
11. Effect of moderate caloric restriction and/or weight cycling on mammary tumor incidence and latency in MMTV-Neu female mice.
Pape-Ansorge KA; Grande JP; Christensen TA; Maihle NJ; Cleary MP
Nutr Cancer; 2002; 44(2):162-8. PubMed ID: 12734063
[TBL] [Abstract][Full Text] [Related]
12. Dietary energy balance modulates signaling through the Akt/mammalian target of rapamycin pathways in multiple epithelial tissues.
Moore T; Beltran L; Carbajal S; Strom S; Traag J; Hursting SD; DiGiovanni J
Cancer Prev Res (Phila); 2008 Jun; 1(1):65-76. PubMed ID: 19138937
[TBL] [Abstract][Full Text] [Related]
13. Low-carbohydrate diet versus caloric restriction: effects on weight loss, hormones, and colon tumor growth in obese mice.
Wheatley KE; Williams EA; Smith NC; Dillard A; Park EY; Nunez NP; Hursting SD; Lane MA
Nutr Cancer; 2008; 60(1):61-8. PubMed ID: 18444137
[TBL] [Abstract][Full Text] [Related]
14. Prevention of mammary tumorigenesis by intermittent caloric restriction: does caloric intake during refeeding modulate the response?
Cleary MP; Hu X; Grossmann ME; Juneja SC; Dogan S; Grande JP; Maihle NJ
Exp Biol Med (Maywood); 2007 Jan; 232(1):70-80. PubMed ID: 17202587
[TBL] [Abstract][Full Text] [Related]
15. IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression.
Ford NA; Nunez NP; Holcomb VB; Hursting SD
Endocr Relat Cancer; 2013 Feb; 20(1):39-51. PubMed ID: 23152442
[TBL] [Abstract][Full Text] [Related]
16. Omega-3-Acid Ethyl Esters Block the Protumorigenic Effects of Obesity in Mouse Models of Postmenopausal Basal-like and Claudin-Low Breast Cancer.
Ford NA; Rossi EL; Barnett K; Yang P; Bowers LW; Hidaka BH; Kimler BF; Carlson SE; Shureiqi I; deGraffenried LA; Fabian CJ; Hursting SD
Cancer Prev Res (Phila); 2015 Sep; 8(9):796-806. PubMed ID: 26100521
[TBL] [Abstract][Full Text] [Related]
17. Energy balance, physical activity, and cancer risk.
Fair AM; Montgomery K
Methods Mol Biol; 2009; 472():57-88. PubMed ID: 19107429
[TBL] [Abstract][Full Text] [Related]
18. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
19. Multimodal biomarker investigation on efficacy and mechanism of action for the mammalian target of rapamycin inhibitor, temsirolimus, in a preclinical mammary carcinoma OncoMouse model: a translational medicine study in support for early clinical development.
Wang X; Zhan Y; Zhao L; Alvarez J; Chaudhary I; Zhou BB; Abraham RT; Feuerstein GZ
J Pharmacol Exp Ther; 2011 Nov; 339(2):421-9. PubMed ID: 21835932
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin inhibits growth of premalignant and malignant mammary lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Abbey CK; Kim L; Damonte P; Borowsky AD; Qi J; Tepper CG; MacLeod CL; Cardiff RD; Gregg JP
Clin Cancer Res; 2006 Apr; 12(8):2613-21. PubMed ID: 16638874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
